Molecular and Therapeutic Significance of sNASP-TRAF6 axis in DEP-exacerbated airway allergic asthma

Yang,F.-M.,Chen,C.-Y.
DOI: https://doi.org/10.1183/13993003.congress-2024.pa5305
IF: 24.3
2024-11-01
European Respiratory Journal
Abstract:Diesel exhaust particles (DEP) has considered as a major emission source of air pollutants from the incomplete combustion of fossil fuel in motor vehicle or heavy-duty industries, which can exacerbate allergic inflammation in the lung. Here, we demonstrated that sNASP-TRAF6 axis is a regulatory checkpoint of TGF-β1 signaling to modulate the DEP-induced allergic response. In our studies, we showed that both DEP and TGF-β1 challenge decreased expression of sNASP via SUMO-dependent proteasomal degradation, which leads to active TRAF6 pathway, and concomitantly caused E-cadherin loss and increase proallergic cytokines (TSLP, IL-25 and IL-33) in bronchial epithelial cells. Similarly, silencing of TRAF6 can restore the E-cadherin loss and decrease proallergic cytokines production. Our data also indicated that administration of cell permeable PEP-sNASP peptide can be therapeutic approach to prevent DEP-induced barrier disruption via targeting TRAF6 signaling. Thus, we suggested that sNASP-TRAF6 axis regulate through different downstream mechanisms and that axis itself may be a viable therapeutic target and a biomarker for allergic asthma.
respiratory system
What problem does this paper attempt to address?